#Active Pharmaceutical Ingredients Market 2019

[industrynewsupdates]

A Deep Dive into the Para Nitrochlorobenzene Market: Insights and Analysis

The global para nitrochlorobenzene market size is projected to reach USD 420.7 million by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.1% over the forecast period. Dyes emerged as the most dominant application of para nitrochlorobenzene (PNCB) in 2019 in terms of revenue on account of growing textile market, especially in the developing countries of Asia Pacific.

China and India are the leading producers of PNCB. The growth in benzene production in China and Southeast Asia is, thus, anticipated to generate feedstock availability for the manufacturers of chlorobenzene and its derivatives. One of the planned capacity expansions is the expansion of the Petronas refinery in Malaysia, which is expected to grow by an additional 667,000 mt/year. Moreover, in May 2019, PetroChina’s Huabei refinery announced an expansion plan to reach 200,000 b/d from 100,000 b/d. These expansions are anticipated to increase the annual benzene supply, especially in Asia, thus benefitting the entire benzene value chain in terms of raw material availability, price, and constant supply.

The benzene supply is anticipated to directly have a positive influence on the production of nitrobenzene, chlorobenzene, styrene, and phenol. Para nitrochlorobenzene is on the third stage of the benzene value chain. Its production is anticipated to be positively influenced by the growth in chlorobenzene production.

In spite of the positive outlook of PNCB production, the consumption is anticipated to be hindered by the stringent regulations on the chemical. Nitrofen and parathion are the active ingredients used in pesticides that are manufactured from para nitrochlorobenzene. Both these chemicals are banned in certain countries mainly due to their insolubility in water, which causes harm to the aquatic life and increases the soil salinity. Thus, demand for para nitrochlorobenzene in pesticide manufacturing is anticipated to grow at a slow pace over the forecast period.

Gather more insights about the market drivers, restrains and growth of the Para Nitrochlorobenzene Market

Para Nitrochlorobenzene Market Report Highlights

• By application, pesticides led the market with a share of 29.5% in 2019 in terms of volume

• Para nitrochlorobenzene and active ingredients manufactured from the chemical are under high scrutiny of various regulatory bodies, which is anticipated to result in slow growth of the product in the agriculture industry with a revenue-based CAGR of 3.8% from 2020 to 2027

• Tire is the major application of rubber and its production has significantly increased in the emerging Asia Pacific countries, including China and India. The rubber chemicals application segment is therefore expected to expand at the fastest revenue-based CAGR of 4.8% from 2020 to 2027

• By end use, the pharmaceuticals segment accounted for 25.3% share of the overall revenue in 2019 and is expected to be the fastest growing segment based on revenue as well as volume over the forecast period

Para Nitrochlorobenzene Market Segmentation

Grand View Research has segmented the global para nitrochlorobenzene market on the basis of application, end use, and region:

Para Nitrochlorobenzene Application Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027)

• Dyes

• Pesticides

• Rubber Chemicals

• Others

Para Nitrochlorobenzene End-Use Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027)

• Agriculture

• Pharmaceuticals

• Chemicals

• Others

Para Nitrochlorobenzene Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027)

• North America

o U.S

o Canada

o Mexico

• Europe

o Germany

o U.K.

o Italy

o France

• Asia Pacific

o China

o India

o Japan

o South Korea

• Central & South America

o Brazil

o Argentina

• Middle East & Africa

o Saudi Arabia

o South Africa

Order a free sample PDF of the Para Nitrochlorobenzene Market Intelligence Study, published by Grand View Research.

[mwseo2024]

Market Trends and Opportunities for Commercial Spirulina Farming

Described as one of the best foods for the future”, Spirulina is now being viewed as a major nutrition source around the globe. This microalga or cyanobacterium contains a broad spectrum of nutrients, proteins, and antioxidants, making this organic substance ideal for many applications in different industries. The spirulina industry has rapidly expanded, with this superfood already in over 40 nations, most commonly for dietary supplementation purposes, however, the spirulina Industry keeps shifting to relaying messages to wider audiences and developing new formulations.

Below, we explore the current market applications of spirulina, as well as emerging trends and opportunities for commercial spirulina farming.

Commercial Spirulina Farming

Commercial spirulina farming is an immense market opportunity because of the rise in infernal concerns about health and well-being by averting people to natural sources of nutrition supplements. The spirulina market was evaluated at more than USD 542.52 million and will go up to approximately USD 1129.55 million by the year 2030 with a CAGR of 9.60%. This examines the market’s focus on spirulina’s traditional role as a dietary Help while considering its other potential related to spirulina marketing health schemes and innovative offerings. The industry has a forecasted growth from 393.6 million in 2019 to approximately 897.61 million by the year 2027 implying good growth prospects and thus new market participants and existing players will have many opportunities in the industry.

As the market grows there are chances in coming up with new products, new ways of farming as well as other uses such as in the cosmetics and pharmaceutical industries.

Exploring Various Spirulina Product Applications in the Market

Colorants-Most industrial products now include spirulina because it enables them to provide a natural blue color. With the rising trend in switching to organic products, spirulina-based colorants are seen as the solution. It is incorporated in the food industry for blue-green coloring as well as in cosmetics and personal care products where natural color is desired.

Food Industry-Spirulina is a common ingredient in functional foods as it is highly nutritious and can be added to numerous foods such as protein bars, and smoothies or even incorporated in snack and pasta production. As a superfood, there is significant demand for spirulina in the ever-growing wellness market as people want to consume food that provides additional benefits.

Supplements-There are powder, tablet, and capsule forms of spirulina supplements that are widely available in the health and wellness market and are considered to be among the highest-selling products. They are acclaimed due to their high antioxidant activity, immune boosting, and as a good source of vitamins and minerals. The market for spirulina supplements is broad and ranges from bodybuilders to anyone who needs protein and vital nutrients of plant origin.

Animal Feed-Spirulina finds application for use in livestock and pet food, especially for aquaculture purposes. Its rich protein content adds significantly to the animal feed’s nutritional value as well which supports the health and growth of the animals. As a feed additive, spirulina has proven to be beneficial to livestock and poultry by improving immunity, digestive health, and general well-being. 

Cosmetics-Spirulina expands to other industries including the cosmetics industry, as its anti-inflammatory and moisturizing properties have also been applied in skincare. Skincare products appreciate their natural antioxidants such as vitamins A and E. Thanks to its ability to enhance skin and reduce ruddiness, it quickly became cherished by both luxury and natural skincare brands.

Fish Feed-Spirulina is now part of fish feed in the aquaculture industry due to its role in stimulating growth and increasing fish color. The carotenoids present in spirulina enhance the color of ornamental fish, and their nutritional benefits allow for a wide range of fish to be incorporated, which is optimal for this market sector.

Global Usage and Versatile Applications

Spirulina’s range of nutrients has seen its use in over 40 countries, most of which are in health-promoting products.

Read the full article on our website to uncover all the emerging trends, commercial farming opportunities, and the bright future of this superfood!

Visit Now to Read More

[marketingreportz]

Fine Chemicals Market - Forecast(2024 - 2030)

Fine Chemicals Market Overview

Request Sample Report :

Fine chemicals are widely used in Pharmaceuticals, Agrochemicals, Construction Materials, Food and Beverages, Electronics, and many more. An increase in construction, and agricultural activities along with an increase in demand for consumer electronics can act as major drivers for the market. Strict rules and regulations regarding the negative effects of the use of fine chemicals on the environment can act as a major constraint for the market.

COVID-19 Impact

There is no doubt that the COVID-19 lockdown has significantly reduced construction, and production activities which in turn, has resulted in the country-wise shutdown of construction sites, shortage of labor, and the decline of supply and demand chain all over the world, thus, affecting the market. Studies show that the outbreak of COVID-19 sharply declined construction activities in 2020 due to a lack of operations across multiple countries around the world. However, a slow recovery in new development and construction contracts has been witnessed across many countries around the world since 2021. For instance, The Iron Bridge Magnetite project that is expected to deliver 22mtpa of high-grade 67 percent Fe magnetite concentrate product is currently undergoing development. The overall cost of the project is expected to reach around £1.96 billion (US$2.35 billion) Mota-Engil. Since the use of fine chemicals plays a major role in the modern construction industry, a slow and steady increase in development, and construction, activities will require the use of fine chemicals for construction materials like adhesives, sealants, inhibitors, heavy reinforcement concrete, protective coating for steel, plastic additives and others. This will eventually lead to an increase in demand for fine chemicals which indicates a slow and steady recovery of the market in the upcoming years.

Inquiry Before Buying :

Report Coverage

The report: “Fine Chemicals Market — Forecast (2022–2027)”, by IndustryARC covers an in-depth analysis of the following segments of the Fine Chemicals Industry.

By Type: Active Pharmaceutical Ingredients, Agrochemicals, and Speciality Chemicals. By Application: Pharmaceuticals, Cosmetics, Agriculture, Electronics, Food and Beverages, Petrochemicals, Plastic, Foundry, Others. By Geography: North America (USA, Canada, and Mexico), Europe (the UK, Germany, France, Italy, and the Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and the Rest of Asia-Pacific), South America (Brazil, Argentina, and the Rest of South America), the Rest of the World (the Middle East, and Africa)

Key Takeaways

Pharmaceuticals in Fine Chemical Market is expected to see the fastest growth, especially during the forecast period. The major reason behind this is the increasing demand and consumption of various medical drugs across the world. For instance, in 2019, the UNDESA published a report, which showed that the majority of the elderly population (approx. 703 billion) have a weaker immune system, hence, they tend to fall sick quite often. This increases the demand for fine chemicals required for the production of medical drugs and medications, hence, leading to market growth.

Asia-Pacific dominated the Fine Chemicals Market in 2021, with countries like China, and India being most likely to drive the market growth. The major reason behind this is the rising requirement of construction materials, cosmetic products, increasing demand for adhesives and plastics from the packaging industry, and more applications that require the use of fine chemicals boost the market growth.

New environmental-friendly methods are being employed in order to reduce the negative effects of fine chemicals on the environment.

For More Details on This Report — Request for Sample

Fine Chemicals Market Segment Analysis — By Type

The Active Pharmaceutical Ingredients segment held the largest share in the Fine Chemicals Market in 2021 and is expected to grow at a CAGR of 5.5 % between 2022 and 2027. The major reason behind this is the fact that active ingredients are the most important component of any drug since they are the ones who are responsible for fulfilling the purpose of the medication. According to a report published by IMS Institute for Healthcare Informatics, the overall volume of medicines used across the globe reached around 4.5 trillion doses by 2020 with an approximate cost of around $1.4 trillion. As the demand for medical drug production in the pharmaceutical sectors in countries across the globe increases, the demand for the use of fine chemicals such as polypeptide, erythropoietin, nucleotides, and more are also expected to rise significantly, which can help boost the market growth.

Likewise, fine chemicals are also widely used in agriculture. Fine chemical intermediates are mostly used in order to protect the crops from pests and add more nutrients to the soil. The major benefit of using fine chemicals in agriculture is the fact that it protects and increases crop yields that play a vital role in the food chain system.

Fine Chemicals Market Segment Analysis — By Application

The Pharmaceuticals held the largest share in Fine Chemicals in 2021 and is expected to grow at a CAGR of 5.9 % between 2022 and 2027. According to the data on therapeutic drug use in the U.S. published by National Centre for Health Statistics, the number of drugs that were ordered and provided through physician office visits reached around 2.9 billion, and the number of drugs that were given or prescribed through hospital emergency department visits reached around 336 million in 2020. Likewise, recent reports published by Kaiser Family Foundation (KFF) show that over 90 million of 246 million U.S. adults fall at a higher risk of serious illness if infected with the coronavirus. Thus, an increased risk of people falling sick or suffering from certain medical illnesses will also increase the demand for medicines or drugs required for the treatment, which can lead to an increase in the demand for fine chemicals required for the production of the medical drugs. This, in turn, will play a major role in leading market growth in the upcoming years.

Furthermore, according to the recent reports published by the Food and Agriculture Organization of the United Nations (FAO) and the International Food Policy Research Institute (IFPRI), the global food demand across the world is most likely to increase significantly. The FAO reports estimate that world food demand is most likely to increase by 70% by 2050, and most of the global food demand is expected to come from regions such as Asia-Pacific, Eastern Europe, and Latin America. Hence, an increase in food demand will significantly increase the demand for the utilization of agrochemicals, food additives, and preservatives that require the use of fine chemicals during their production, hence, boosting the market growth.

Schedule A Call :

Fine Chemicals Market Segment Analysis — By Geography

The Asia Pacific held the largest share in the Fine Chemicals Market in 2021 up to 30 %. A recent study indicates that the total sales revenue of traditional pharmaceuticals in China amounted to about $28.8 billion in 2019 and is expected to increase in the upcoming years. Likewise, recent reports from India Brand Equity Foundation (IBEF) show that the Indian pharmaceutical sector supplies over 50% of the global demand for various vaccines, 40% of the generic demand for the US, and 25% of all medicines for the UK during the ongoing COVID-19 pandemic. It also states that India holds the second-largest share of the pharmaceutical and biotech workforce in the world. According to the Indian Economic Survey 2021, the domestic pharmaceutical market is estimated to grow 3x in the next decade. Similarly, under Union Budget 2021–22, the Ministry of Health and Family Welfare has been allotted INR 73,932 crore (US$ 10.35 billion) and the Department of Health Research has been allotted INR 2,663 crore (US$ 365.68 billion). The government allotted INR 37,130 crore (US$ 5.10 billion) to the ‘National Health Mission’.

India plans to allocate nearly INR 1 lakh crore (US$ 1.3 billion) funds to boost companies to manufacture pharmaceutical ingredients domestically by 2023. Hence, in this way, an increase in demand for medicines and drugs from pharmaceutical sectors across multiple countries will eventually lead to an increase in demand for fine chemicals such as polypeptide, erythropoietin, nucleotides, and more required for their production as well.

Furthermore, the Middle East also saw significant growth in Fine Chemicals Market in 2021. Fine chemicals are also widely used in the production of construction materials across the world. The FIFA World Cup that is to be held in 2022 in Qatar is expected to generate the huge potential for construction materials used in the country. A company called Larsen and Toubro signed a contract worth $ 360 million along with its joint venture partner in Qatar, in order to build a 40,000 seater stadium. This project required the use of construction materials like adhesives, sealants, inhibitors, heavy reinforcement concrete, protective coating for steel, and other raw materials in order to build such a huge stadium. Likewise, other countries such as Kuwait, Morocco, and Iran are also estimated to have higher growth in the construction sector during the forecast period. All of the above factors will directly result in an increase in demand for fine chemicals required for the production of these raw materials in these regions, thus, boosting the market growth.

Fine Chemicals Market Drivers

An increase in construction and production activities in the Asia-Pacific region is most likely to increase market demand

Construction and production activities are considered to be the pillar of growth for a country and also play a major role in increasing the overall global economy. According to recent studies, Asia-Pacific is expected to be the largest market for fine chemicals in the construction and manufacturing sector. Since 2019, countries like China and India have come up with multiple construction projects. For instance, the Indian government had made an announcement of the World One Tower project which is to be built in Mumbai. World One is a residential skyscraper that also houses two other smaller towers. It consists of 117 floors and is over 440 meters in height. $290 million has been invested so far and the project is still ongoing and under development. Similarly, the Indian government has also invested in another construction project for building Gujarat International Finance Tec-City. The project is valued at a total cost of US$20 billion and is expected to cover a construction area of around 8.5 million square meters which will include 200 skyscrapers. The project also includes the construction of buildings and towers for the powerhouse. Furthermore, the government of China approved 26 infrastructure projects with an estimated total investment of 981.7 billion yuan ($ 142 billion) in 2019. Other countries like Bangladesh also have two ongoing power plant projects estimated at $17.65 billion in total which is due delivery by 2025.

In this way, an increase in construction and development activities will most likely increase the demand for raw materials such as adhesives, sealants, inhibitors, heavy reinforcement concrete, protective coating for steel, pigments, and dye, plastic additives, and other raw materials. Since fine chemicals are widely used for the production of these construction materials due to the properties that it provides like longer durability, higher thermal resistance, high strength, and better resistance to corrosion, this can lead to significant growth in Fine Chemicals Market in the upcoming years.

An increase in agricultural activities in the Asia-Pacific region is most likely to increase demand for the product

Fine chemicals are widely used in agricultural fertilizers in order to protect the crops from pests and add more nutrients to the soil. Recent insights from “Statistics Times” show that China is the leading contributor to the agricultural economy with 19.49% of the total global agricultural output, followed by India with 7.39%. An increase in agricultural activities and production also increases the demand for fertilizers that use fine chemicals, thus, resulting in the growth of the Fine Chemicals Market in the upcoming years.

Fine Chemicals Market Challenges

Strict environmental regulations can cause an obstruction to the market growth

Strict rules and regulations regarding the negative effects of fine chemicals on the environment can act as a major constraint for the market. These include regulation and initiatives taken by industrial associations in order to set standards for the management of an organization’s environmental impacts, product certification and issuance of licenses to decrease the harmful impact on the environment and adoption of clean technologies, and improvement in management practices under CREP (Corporate Responsibility for Environmental Protection) Programmes formulated by the Central Pollution Control Board.

However, several governments are spending and working on research and development in order to reduce environmental pollution associated with the fine chemicals industry. For instance, the Government of China has made investments in high and advanced technology, clean production, manufacturing of equipment or new materials, use of renewable energies, recycling, and environmental protection.

Buy Now :

Fine Chemicals Industry Outlook

Technology launches, acquisitions, and R&D activities are key strategies adopted by major players in this market. Fine Chemicals top 10 companies include:

Sumitomo Chemicals(JAP)

BASF SE

GlaxoSmithKline plc(UK)

Chemada Fine Chemicals(Israel )

Syntor Fine Chemicals(UK)

GlaxoSmithKline plc(UK)

Lonza(Swiss)

Boehringer-Ingelheim(GERMANY)

Pfizer Inc(US)

Johnson Matthey Fine Chemicals(EU)

Acquisitions/Technology Launches

In August 2021, BASF and SINOPEC announced to further expand their Verbund site functioned by BASF-YPC Co., Ltd. (BASF-YPC), which is a 50–50 joint venture of both companies in Nanjing, China. It involves the capacity extension of numerous downstream chemical plants, including a new tert-butyl acrylate plant in order to support the growing Chinese market.

In August 2021, Sumitomo Chemical announced to further expand its production capacity for high-purity chemicals for semiconductors. It announced that it will install new production lines in order to increase the capacity for high-purity sulfuric acid at its Ehime Works (Niihama City, Ehime, Japan) along with increasing the capacity for high-purity ammonia water at the Iksan Plant of Dongwoo Fine-Chem Co. Ltd.

Relevant Reports

Specialty Chemicals Market — Forecast (2021–2026)

Report Code: CMR 12114

Specialty Oilfield Chemicals Market — Forecast (2021–2026)

Report Code: CMR 0097

For more Chemicals and Materials Market reports, please click here

[shobhaalss]

The Glimepiride API Market: Trends, Growth, and Future Outlook

The Glimepiride API Market: Trends, Growth, and Future Outlook

The pharmaceutical industry is continuously evolving, with the development of active pharmaceutical ingredients (APIs) playing a crucial role in ensuring the effectiveness of medicines. One such API that has gained significant attention in recent years is Glimepiride, a widely used medication for managing Type 2 diabetes. In this blog post, we’ll explore the Glimepiride API market, including its growth drivers, key players, and future outlook.

What is Glimepiride?

Glimepiride is a second-generation sulfonylurea drug that is used primarily for managing Type 2 diabetes. It works by increasing insulin production from the pancreas and enhancing the body’s sensitivity to insulin, helping to regulate blood sugar levels. As part of a comprehensive diabetes management regimen, Glimepiride is often used in combination with other anti-diabetic medications when blood sugar levels cannot be controlled by diet and exercise alone.

The Growing Demand for Glimepiride API

The increasing global prevalence of Type 2 diabetes is one of the key factors driving the demand for Glimepiride API. According to the World Health Organization (WHO), the number of people suffering from diabetes worldwide is steadily rising, with an estimated 463 million adults affected by the condition in 2019. This trend is expected to continue, leading to greater demand for anti-diabetic medications, including Glimepiride.

The high prevalence of Type 2 diabetes, especially in emerging markets like Asia Pacific, Latin America, and the Middle East, has created substantial growth opportunities for the Glimepiride API market. In these regions, the growing awareness about diabetes management, coupled with improvements in healthcare infrastructure, is further fueling the demand for diabetes medications, including Glimepiride.

Market Drivers

Several factors are contributing to the growth of the Glimepiride API market:

Rising Prevalence of Type 2 Diabetes: As mentioned earlier, the increasing number of diabetes cases globally is the primary driver behind the growth of the Glimepiride API market. Both lifestyle factors (such as poor diet, lack of exercise, and obesity) and genetic factors contribute to the rising incidence of Type 2 diabetes.

Aging Population: The global population is aging, and older individuals are more likely to develop Type 2 diabetes. As the elderly population continues to grow, the demand for diabetes medications like Glimepiride will increase.

Cost-Effectiveness: Glimepiride is generally considered an affordable and effective treatment for Type 2 diabetes. With increasing healthcare costs worldwide, many healthcare systems are focusing on providing cost-effective alternatives to newer and more expensive diabetes medications, further boosting the demand for Glimepiride.

Advancements in Drug Formulations: The development of new formulations, such as combination therapies involving Glimepiride and other anti-diabetic agents, is another factor contributing to market growth. These combination drugs offer improved convenience for patients and better blood sugar control.

Generic Market Growth: As the patent for Glimepiride has expired, generic versions of the drug have flooded the market. This has not only made Glimepiride more affordable for patients but has also increased the availability of the API for pharmaceutical companies.

Key Players in the Glimepiride API Market

The Glimepiride API market is characterized by the presence of several established players that manufacture and supply the drug. Some of the leading companies in this market include:

Dr. Reddy’s Laboratories: Based in India, Dr. Reddy’s is one of the prominent players in the global generic pharmaceutical market. The company manufactures Glimepiride API and offers it to various pharmaceutical companies worldwide.

Aurobindo Pharma: Another major Indian pharmaceutical company, Aurobindo Pharma produces Glimepiride APIs and supplies them to both domestic and international markets.

Sun Pharmaceutical Industries: As one of the largest pharmaceutical companies in India, Sun Pharma manufactures a range of generic drugs, including Glimepiride.

Mylan Pharmaceuticals (now part of Viatris): Mylan, now part of Viatris, is a global leader in the production of generic medications, including Glimepiride.

Zydus Cadila: Zydus Cadila is a significant player in the global API market and produces Glimepiride as part of its portfolio of anti-diabetic medications.

In addition to these, numerous other manufacturers based in China, India, and Europe contribute to the global supply of Glimepiride API.

Challenges in the Glimepiride API Market

While the Glimepiride API market is growing, it is not without its challenges:

Regulatory Hurdles: The pharmaceutical industry is highly regulated, with stringent requirements for the production and sale of APIs. Companies need to adhere to Good Manufacturing Practices (GMP) and other international standards, which can be a costly and time-consuming process.

Price Pressure: The global shift towards generic drugs has led to significant price competition in the market. While this benefits patients by reducing medication costs, it puts pressure on API manufacturers to maintain profitability amidst price reductions.

Supply Chain Issues: Disruptions in the global supply chain, such as those caused by the COVID-19 pandemic, can affect the availability of raw materials and finished APIs. This poses a challenge for companies relying on consistent production and delivery schedules.

Market Fragmentation: With numerous players in the market, especially in emerging markets, the Glimepiride API market can be fragmented, making it difficult for companies to maintain significant market share.

[umadeochake]

Global Oncology Active Pharmaceutical Ingredient (API) Market Size: Regional Outlook and Analysis 2024-2036

Research Nester published a report titled “Oncology Active Pharmaceutical Ingredient (API) Market: Global Demand Analysis & Opportunity Outlook 2036” which delivers a detailed overview of the global oncology active pharmaceutical ingredient (API) marketin terms of market segmentation by APIs, manufacturing type, type of cancer, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, and supply and demand risk, along with a detailed discussion of current and future market trends that are associated with the growth of the market.

The global oncology active pharmaceutical ingredient (API) market is projected to grow at a CAGR of ~7% by attaining robust revenue during the forecast period, i.e., 2022 – 2031. Rising cases of cancer worldwide are anticipated to propel the growth of the market during the forecast period. World Health Organization (WHO) published a report representing that in 2020, around 10 million deaths were caused by cancer. The rising prevalence of medication errors is also estimated to fuel the market growth over the forecast period. U.S. FDA stated that it receives over 100,000 reports of medication errors in 2019.

Request Free Sample Copy of this Report @ https://www.researchnester.com/sample-request-4213

Additionally, by type of cancer, the global oncology active pharmaceutical ingredient (API) market is segmented into breast, cervical, lung, liver, colorectal, and others. Out of these sub-segments, the breast cancer segment is estimated to obtain the largest share in the market during the forecast period. The growth of the segment can be accounted to the higher prevalence of breast cancer. Based on the data provided by the World Health Organization, it was stated that in 2020, nearly 2.26 million cases of breast cancer were noticed across the globe.

Furthermore, the global oncology active pharmaceutical ingredient (API) market, by region, is bifurcated into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Out of these regions, the market in the North America region is estimated to grow at a rapid pace over the forecast period on the back of escalating cases of cancer. Centers for Disease Control and Prevention showed that in 2019, 1,752,725 new cases emerged while 599,589 people die due to cancer in a similar year.

The research is global in nature and covers a detailed analysis of the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of the Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook, etc. have also been covered and displayed in the research report.

Rising Consumption of Tobacco and Cigarettes to Foster the Growth of the Market

For instance, nearly 12 out of 100 adults in the USA region smoke cigarettes in 2020.

Request for customization @

https://www.researchnester.com/customized-reports-4213

Tobacco and cigarettes are considered to be the main cause of cancer and are consumed heavily by adults across the globe. Such heavy consumption is prohibited yet people do not hesitate to consume tobacco and cigarettes. Hence, such a significant requirement is estimated to hike the growth of the market over the forecast period.

However, possibilities of side effects and higher prices associated with the manufacturing procedure are expected to operate as a key restraint to the growth of the global oncology active pharmaceutical ingredient (API) market over the forecast period.

This report also provides the existing competitive scenario of some of the key players in the global oncology active pharmaceutical ingredient (API) market which includes company profiling of Merck & Co. Inc., Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., GSK plc, AbbVie Inc., Teva Pharmaceutical Industries Ltd., and Eli Lilli and Company.

The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials, and recent news and developments. On the whole, the report depicts a detailed overview of the global oncology active pharmaceutical ingredient (API) market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching for possibilities, and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.

Access our detailed report @

https://www.researchnester.com/reports/oncology-active-pharmaceutical-ingredient-api-market/4213

About Research Nester-

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[saltypeanutnerd]

Oxyde de styrène, Prévisions de la Taille du Marché Mondial, Classement et Part de Marché des 4 Premières Entreprises

Selon le nouveau rapport d'étude de marché “Rapport sur le marché mondial de Oxyde de styrène 2024-2030”, publié par QYResearch, la taille du marché mondial de Oxyde de styrène devrait atteindre 108 millions de dollars d'ici 2030, à un TCAC de 3.2% au cours de la période de prévision.

Figure 1. Taille du marché mondial de Oxyde de styrène (en millions de dollars américains), 2019-2030

Figure 2. Classement et part de marché des 4 premiers acteurs mondiaux de Oxyde de styrène (Le classement est basé sur le chiffre d'affaires de 2023, continuellement mis à jour)

Selon QYResearch, les principaux fabricants mondiaux de Oxyde de styrène comprennent Yingyang, Harmony Organics, etc. En 2023, les trois premiers acteurs mondiaux détenaient une part d'environ 80.0% en termes de chiffre d'affaires.

According to QYResearch, the global key manufacturers of Styrene Oxide include Yingyang, Harmony Organics, etc. In 2023, the global top three players had a share approximately 80.0% in terms of revenue.

The styrene oxide market is influenced by several key drivers that contribute to its growth and demand:

1. Applications in Chemical Synthesis: Styrene oxide serves as a versatile intermediate in chemical synthesis, particularly in the production of various derivatives used in industries such as pharmaceuticals, cosmetics, and agriculture. It is a precursor to chemicals like 1-phenylethanol, which is used in fragrance production.

2. Demand from Pharmaceuticals: One of the primary drivers is the pharmaceutical industry, where styrene oxide is utilized in the synthesis of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. It finds applications in drugs for neurological disorders, cardiovascular diseases, and other therapeutic areas.

3. Growing Personal Care Industry: Styrene oxide is used in the production of personal care products such as perfumes, deodorants, and cosmetics. The expanding global personal care market, driven by increasing disposable incomes and changing consumer preferences towards personal grooming, contributes to the demand for styrene oxide.

4. Agricultural Chemicals: In agriculture, styrene oxide derivatives are used in the synthesis of pesticides and herbicides. The demand for agrochemicals continues to grow globally due to the need for enhanced crop yields and pest control, further boosting the market for styrene oxide.

5. Environmental Regulations and Substitution Trends: Regulatory policies aimed at reducing volatile organic compound (VOC) emissions and environmental impact drive the demand for safer chemical alternatives. Styrene oxide and its derivatives, being versatile and meeting regulatory requirements, are preferred choices in industries seeking to comply with stringent environmental regulations.

6. Technological Advancements: Advances in chemical processes and manufacturing technologies improve the efficiency of styrene oxide production, making it more cost-effective and environmentally sustainable. These advancements also enable the development of new applications and formulations that expand its market potential.

7. Regional Economic Growth: Economic growth in emerging markets, particularly in Asia-Pacific and Latin America, contributes significantly to the demand for styrene oxide. These regions are witnessing rapid industrialization, urbanization, and growth in sectors such as pharmaceuticals and personal care, driving the market forward.

Overall, the styrene oxide market is driven by its versatile applications across various industries, technological innovations in production processes, regulatory compliance requirements, and the expanding global demand for chemicals used in pharmaceuticals, personal care, and agriculture.

À propos de QYResearch

QYResearch a été fondée en 2007 en Californie aux États-Unis. C'est une société de conseil et d'étude de marché de premier plan à l'échelle mondiale. Avec plus de 17 ans d'expérience et une équipe de recherche professionnelle dans différentes villes du monde, QYResearch se concentre sur le conseil en gestion, les services de base de données et de séminaires, le conseil en IPO, la recherche de la chaîne industrielle et la recherche personnalisée. Nous société a pour objectif d’aider nos clients à réussir en leur fournissant un modèle de revenus non linéaire. Nous sommes mondialement reconnus pour notre vaste portefeuille de services, notre bonne citoyenneté d'entreprise et notre fort engagement envers la durabilité. Jusqu'à présent, nous avons coopéré avec plus de 60 000 clients sur les cinq continents. Coopérons et bâtissons ensemble un avenir prometteur et meilleur.

QYResearch est une société de conseil de grande envergure de renommée mondiale. Elle couvre divers segments de marché de la chaîne industrielle de haute technologie, notamment la chaîne industrielle des semi-conducteurs (équipements et pièces de semi-conducteurs, matériaux semi-conducteurs, circuits intégrés, fonderie, emballage et test, dispositifs discrets, capteurs, dispositifs optoélectroniques), la chaîne industrielle photovoltaïque (équipements, cellules, modules, supports de matériaux auxiliaires, onduleurs, terminaux de centrales électriques), la chaîne industrielle des véhicules électriques à énergie nouvelle (batteries et matériaux, pièces automobiles, batteries, moteurs, commande électronique, semi-conducteurs automobiles, etc.), la chaîne industrielle des communications (équipements de système de communication, équipements terminaux, composants électroniques, frontaux RF, modules optiques, 4G/5G/6G, large bande, IoT, économie numérique, IA), la chaîne industrielle des matériaux avancés (matériaux métalliques, polymères, céramiques, nano matériaux, etc.), la chaîne industrielle de fabrication de machines (machines-outils CNC, machines de construction, machines électriques, automatisation 3C, robots industriels, lasers, contrôle industriel, drones), l'alimentation, les boissons et les produits pharmaceutiques, l'équipement médical, l'agriculture, etc.

[giresearch]

Large-Scale Preparative SFC System Market Insights and Global Outlook 2024-2030

Global Info Research announces the release of the report “Global Large-Scale Preparative SFC System Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030” . This report provides a detailed overview of the market scenario, including a thorough analysis of the market size, sales quantity, average price, revenue, gross margin and market share.The report provides an in-depth analysis of the competitive landscape, manufacturer’s profiles,regional and national market dynamics, and the opportunities and challenge that the market may be exposed to in the near future. Global Large-Scale Preparative SFC System market research report is a comprehensive analysis of the current market trends, future prospects, and other pivotal factors that drive the market. A Large-Scale Preparative SFC (Supercritical Fluid Chromatography) System is a specialized chromatographic system used for separating and purifying chemical compounds on a larger scale compared to analytical SFC systems. SFC is a chromatographic technique that utilizes supercritical fluids, typically carbon dioxide (CO2), as the mobile phase instead of liquid solvents used in traditional liquid chromatography (LC). The preparative SFC system is equipped with high-capacity columns, robust pumps, and precise control systems designed to handle large quantities of sample material. It is employed primarily in pharmaceutical, chemical, and natural product industries for the isolation and purification of active pharmaceutical ingredients (APIs), natural products, and fine chemicals. These systems enable efficient separation of complex mixtures, offering advantages such as faster separation times, reduced solvent consumption, and the ability to process thermally labile compounds without degradation. Future developments in large-scale preparative SFC systems may focus on improving automation, scalability, and integration with other analytical techniques to meet the growing demand for efficient purification processes in drug discovery and chemical synthesis applications. According to our (Global Info Research) latest study, the global Large-Scale Preparative SFC System market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period. This report is a detailed and comprehensive analysis for global Large-Scale Preparative SFC System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Market Segmentation Large-Scale Preparative SFC System market is split by Type and by Application. For the period 2019-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. Market segment by Type: Semi-preparative、Preparative Market segment by Application:Pharmaceutical、Chemical、Food and Beverage、Environmental、Biotechnology、Others Major players covered: Waters、Sepiatec、Shimadzu Scientific Instruments、JASCO、Teledyne ISCO、Agilent Technologies、Hanbon The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Large-Scale Preparative SFC System product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Large-Scale Preparative SFC System, with price, sales, revenue and global market share of Large-Scale Preparative SFC System from 2019 to 2024. Chapter 3, the Large-Scale Preparative SFC System competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Large-Scale Preparative SFC System breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Large-Scale Preparative SFC System market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030. Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis. Chapter 13, the key raw materials and key suppliers, and industry chain of Large-Scale Preparative SFC System. Chapter 14 and 15, to describe Large-Scale Preparative SFC System sales channel, distributors, customers, research findings and conclusion. Our Market Research Advantages： Global Perspective: Our research team has a strong understanding of the  company in the global Large-Scale Preparative SFC System market.Which offers pragmatic data to the company. Aim And Strategy: Accelerate your business integration, provide professional market strategic plans, and promote the rapid development of enterprises. Innovative Analytics: We have the most comprehensive database of resources , provide the largest market segments and business information. About Us: Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provide market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.

[spookysaladchaos]

Vegetarian Softgel Capsules for Supplements, Global Top 10 Players, Market Share and Ranking (2023)

Vegetarian Softgel Capsules for Supplements Market Summary

Vegetarian Softgel Capsule is a kind of Softgels, with a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. 

This report only focus on the health supplements that use Vegetarian Softgel Capsule. OTC and Rx product is not included in this report.

According to the new market research report “Global Vegetarian Softgel Capsules for Supplements Market Report 2024-2030”, published by QYResearch, the global Vegetarian Softgel Capsules for Supplements market size is projected to reach USD 0.54 billion by 2030, at a CAGR of 5.6% during the forecast period.

Figure.   Global Vegetarian Softgel Capsules for Supplements Market Size (US$ Million), 2019-2030

Figure.   Global Vegetarian Softgel Capsules for Supplements Top 10 Players Ranking and Market Share (Ranking is based on the revenue of 2023, continually updated)

According to QYResearch Top Players Research Center, the global key manufacturers of Vegetarian Softgel Capsules for Supplements include Catalent, Sirio Pharma, Aenova, Bahrain Pharma, Robinson Pharma, Eurocaps, Procaps, Sunsho Pharmaceutical, Captek, Aland, etc.

In 2023, the global top five players had a share approximately 68.0% in terms of revenue.

Figure.   Vegetarian Softgel Capsules for Supplements, Global Market Size, Split by Product Segment

In terms of product type, currently Carrageenan is the largest segment, hold a share of 89.3%.

Figure.   Vegetarian Softgel Capsules for Supplements, Global Market Size, Split by Application Segment

In terms of product application, currently Vitamins and Minerals is the largest segment, hold a share of 35.9%.

Figure.   Vegetarian Softgel Capsules for Supplements, Global Market Size, Split by Region

About QYResearch

QYResearch founded in California, USA in 2007. It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

[researchrealmblog]

What Are Most-Significant Applications of Industrial Refrigeration Systems?

The ongoing COVID-19 pandemic has put the spotlight on the global healthcare ecosystem, as many of the myths about how advanced the medical infrastructure around the world is were busted. With the case and death counts rising, the industry was caught gasping for breath (metaphorically), while the patients were literally gasping for breath (COVID is a lung infection). During this time, the number of research studies being conducted in the pharmaceutical and healthcare sectors on virology skyrocketed, as a vaccine was to be the leader of the charge against the pandemic.

Therefore, the number of clinical trials being conducted for viral vaccines rose massively, as did the worldwide trade of vaccines, aided by several such products getting regulatory approvals. With the healthcare and pharmaceutical sectors expected to not drop their guard for many years to come, the industrial refrigeration systems market size, as calculated by P&S Intelligence, is predicted to increase to $41.1 billion in 2030 from $26.8 billion in 2019, at a 5.0% CAGR between 2020 and 2030.

This is because an efficient, unbroken cold chain is essential for drug development and trade. Refrigerators are not only used to store and transport the final pharmaceutical products but also for the storage and transportation of the raw materials. Pharmaceuticals, biosimilars, excipients, active ingredients, tissues, and blood products are extremely sensitive to heat; therefore, effective cooling is necessary to protect them from damage and make them viable for use over a long time.

Another sector where refrigeration is important for the same reason is food and beverage. Most agricultural products spoil in the heat, which is why keeping them in cool conditions is paramount. Several of the processed food packages carry the directions “store in a cool and dry place”. In food processing factories, the ingredients, intermediate goods, and final products must be refrigerated to increase their shelf life. Thus, with the rising disposable income allowing people in developing countries to purchase processed food, the demand for industrial-grade refrigerators among food and beverage companies is surging.

Other industries where refrigeration is vital are oil and gas, construction, and manufacturing. Since, the food and beverage sector has been the largest user of such systems, their sales have been the highest in Asia-Pacific (APAC). Home to the largest number of people in the world, APAC has the most-productive food and beverage industry. India is already home to the fifth-largest processed food industry, which continues to garner extensive government support. “…the food processing sector in India has received around US$ 7.54 billion worth of Foreign Direct Investment (FDI) during the period April 2000-March 2017.”, says the India Brand Equity Foundation (IBEF).

Moreover, recently, the Indian government announced plans to establish 40 mega food parks, which are essentially integrated manufacturing districts for the food and beverage sector. With this, the industrial refrigeration systems market is poised for strong growth, with such equipment being important in this industry. Moreover, Invest India expects the country’s food processing sector to value more than $500 billion by 2025, which reflects a consistently growing demand for processing equipment.

Hence, with the pharmaceutical and food and beverage production growing, the procurement of industrial-grade refrigerators will escalate too.

[esglatestmarketnews]

Driving Change: Antibiotics Industry Embraces ESG Principles

C-suite executives and board members in the antibiotics industry have become increasingly aware of ESG and how it affects their strategy, companies’ future performance and their value. An ominous rise of antibiotic-resistant bacteria has sent shockwaves among manufacturers, compelling them to integrate ESG into their business operations. The Lancet noted in its 2021 study that antibiotics helped minimize the mortality of under-fives to 39 deaths (from 216) per 1,000 live births between 1950 and 2017. Meanwhile, the overuse of antibiotics has led to a notable outcry towards the emergence and prevalence of antimicrobial resistance (AMR). Citing the Global Research on AntiMicrobial Resistance (GRAM), the Lancet (in January 2022) suggested at least 1.27 million people succumbed to AMR in 2019.

Amidst havoc wracked by antibiotic resistance, traction for impact investing, socially responsible investing and the European Sustainable Finance Disclosure Regulation (SFDR) have risen by leaps and bounds. A report by the World Bank claimed that by 2050, drug-resistant infections could cause global economic damage akin to the 2008 financial crisis, while healthcare costs could soar to USD 1 trillion. 

Stakeholders are relying on impact investing to have a positive impact on the environment and society and generate financial returns. Besides, the adoption of science-based targets, commitment to reduce carbon footprint, investments in transparency, ethics, diversity and health & wellbeing will be a step forward towards adopting ESG best practices. 

Is your business one of participants to the Antibiotics Industry ESG? Contact us for focused consultation around ESG Investing, and help you build sustainable business practices

Pfizer Inc. Invests in Environmental Initiatives for Value Creation

A robust ESG proposition can help organizations expand into existing markets and tap new ones. Industry leaders’ emphasis on reducing carbon footprint, minimization of waste and resource conservation have topped their agenda. Pfizer, for example, has set an audacious target of minimizing scope 1 and 2 GHG emissions by 46% (from a 2019 baseline) by 2030. In 2022, the company claimed to have eradicated around 50,000 mt of GHG emissions by transitioning other product shipments from air to ocean. Besides, in November 2022, the U.S.-based company contemplated joining “Activate,” a collective action initiative, to underscore decarbonization of major sources of GHG emissions in the pharmaceutical value chain. 

Pfizer is gearing up to limit the discharge of active pharmaceutical ingredients (from manufacturing processes to wastewater) using emission control practices and technologies and environmental risk assessment methodologies. The behemoth asserts it is on course to achieve the industry-published targets (Predicted No Effect Concentrations) for antibiotics by 2025.  

Merck Roots for Diverse, Inclusive and Healthy Workforce

At a time when the world is recuperating from COVID-19 and combating inequities in health outcomes, medicines and vaccine accessibility and affordability have become a vital cog in expanding healthcare access. Merck is emphasizing granting voluntary licenses to generic manufacturers and to the Medicines Patent Pool to make generic treatment available in over 100 low- and middle-income countries, provided local regulatory agencies give the nod and emergency authorization. It has also taken a giant leap in fostering diversity, equity and inclusion (DEI). The multinational company alluded to a 5% rise in the representation of underrepresented ethnic groups (UEGs) from 2020 to 2021. The pharmaceutical player is pushing for gender parity in leadership positions by 2030 and has ramped up the share of women (in leadership positions) to 38% in 2022. 

The healthcare giant has expanded its employee networks with (including but not limited to) Rainbow Networks, Inclusion Networks, Well-being Communities and Women Networks. Rainbow Networks, for example, boosts an inclusive and safe environment and community where LGBTQ+ employees and allies are “recognized and valued.” In its 2022 Sustainability Report, Merck noted that the Uhlala Group chose them as one of the top 11 large companies in the LGBTIQ+ Diversity Performance Index. 

AbbVie Counts on Governance for Success in the Boardroom

The confluence of environmental, social and governance pillars has allowed companies not only to survive but also thrive. To put this in perspective, strong corporate governance has become second to none to stay cut above the rest and build a culture of ethical behavior. In the 2022 ESG Action Report, AbbVie inferred that ten of its eleven directors were independent. The company claims that 99% of assigned employees are certified to the AbbVie Code of Business Conduct. The American pharmaceutical company has reinforced the risk assessment process by establishing an annual risk landscape, while the assessment results and mitigation plans are formally documented biannually. 

Ethical decision-making and transparency are instrumental in promoting accountability, quality, integrity and safety. AbbVie exhorted in the report that it assesses its efforts in line with the United Nations Sustainable Development Goals (UN SDGs), the Task Force on Climate-Related Financial Disclosures (TCFD), Carbon Disclosure Project (CDP), the Sustainability Accounting Standards Board (SASB) and the S&P Global Corporate Sustainability Assessment. In 2023, the company took a meaningful step by updating its TCFD report to foster governance and strategy efforts to manage climate risks and highlight “approved” science-based targets to the Science Based Targets initiative. Besides, in 2022, it rolled out an “Acting with Integrity” initiative to undergird ethical and compliant behavior.  

ESG Matters

ESG strategies have turned out to be an invaluable portfolio for responsible investors. Companies that care about their customers, people and environment can outperform their peers. A sustainable approach will help organizations enhance health outcomes, create shared value, make a positive impact on society and build trust. In November 2023, Melinta Therapeutics and Venatorx Pharmaceuticals entered into a license agreement to commercialize cefepime-taniborbactam in the U.S. The collaboration comes against the backdrop of the latter’s submission of a new drug application for cefepime-taniborbactam for the treatment of complicated urinary tract infections (cUTI). With ESG gaining traction globally, Grand View Research has predicted the antibiotics market will grow at 4.5% CAGR between 2021 and 2028.

Related Reports:

Pharmaceutcial Manufacturing Industry ESG: https://astra.grandviewresearch.com/pharmaceutical-manufacturing-industry-esg-outlook

Brain Health Supplement Industry ESG: https://astra.grandviewresearch.com/brain-health-supplement-industry-esg-outlook

Clinical Trials Industry ESG: https://astra.grandviewresearch.com/clinical-trials-industry-esg-outlook

About Astra – ESG Solutions By Grand View Research

Astra is the Environmental, Social, and Governance (ESG) arm of Grand View Research Inc. – a global market research publishing & management consulting firm.

Astra offers comprehensive ESG thematic assessment & scores across diverse impact & socially responsible investment topics, including both public and private companies along with intuitive dashboards. Our ESG solutions are powered by robust fundamental & alternative information. Astra specializes in consulting services that equip corporates and the investment community with the in-depth ESG research and actionable insight they need to support their bottom lines and their values. We have supported our clients across diverse ESG consulting projects & advisory services, including climate strategies & assessment, ESG benchmarking, stakeholder engagement programs, active ownership, developing ESG investment strategies, ESG data services, build corporate sustainability reports. Astra team includes a pool of industry experts and ESG enthusiasts who possess extensive end-end ESG research and consulting experience at a global level.

Read more ESG Blogs

[rupalic]

Microencapsulation Market: Key Factors behind Market’s Rapid Growth

The report "Microencapsulation Market by Technology (Spray, Emulsion, Dripping), Core Material (Pharma & Healthcare Drugs, PCM, Food Additives, Fragrances), Application (Pharma, Household, Agrochemicals, Textiles), Shell Material, and Region - Global Forecast To 2025", The global microencapsulation market was valued at USD 8.5 billion in 2020 and is projected to reach USD 15.5 billion by 2025 at a CAGR of 12.9% from 2020 to 2025. The market is driven by factors such as the increasing demand for fortified food products with health benefits, the increasing demand for agrochemicals due to its controlled release property, growth in construction and construction materials, as well as the widespread application in household & personal care.

North America is estimated to dominate the microencapsulation market in 2020

North America accounted for the largest market share of the microencapsulation market in 2019. The market for microencapsulation in the North American region is driven by the growing demand and awareness for value-added products in various areas such as nutrition, food, healthcare, and personal care. Due to this awareness and increased demand, companies are focusing on manufacturing functional products, with novel technologies such as microencapsulation.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=83597438

This report includes a study on the marketing and development strategies, along with a study on the service portfolios of the leading companies. It includes the profiles of leading companies such as BASF (Germany), Royal FrieslandCampina (Netherlands), Syngenta Crop Protection (Switzerland), Koninklijke DSM (Netherlands), Givaudan (Switzerland), Firmenich (Switzerland), Symrise (Germany), International Flavors & Fragrances (US), Sensient Technologies (US), Lycored Corp. (UK), Balchem Corporation (US), Encapsys (US), Arcade Beauty (US), and Koehler Innovative Solutions (Germany), Ingredion Incorporation (US), Kerry (Ireland), Cargill (US), Firmenich Incorporation (Switzerland), Dupont (US), Aveka Group (US), Advanced Bionutrition Corp (US), Tastetech Encapsulation Solutions (UK), Sphera Encapsulation (Italy), Clextral (France), Vitasquare (Netherlands), and Microtek (US).

The pharmaceuticals and healthcare drugs segment, by application, is estimated to account for the largest share in 2020

Based on application, the microencapsulation market is segmented into pharmaceutical & healthcare products, household & personal care products, food & beverages, agrochemicals, textiles, construction materials, and others. The pharmaceuticals and healthcare drugs segment is estimated to account for the largest market share in 2020. The rising demand for pharmaceutical drugs is expected to drive the demand for the market.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=83597438

Market Driver: Increase in demand for fortified food products with health benefits

The demand for microencapsulation is increasing with the growth in demand for functional and fortified food & pharmaceutical products. Microencapsulation provides integration of minerals, vitamins, flavors, essential oils, and other additives in food products to enhance the functional properties of products. The pharmaceutical sector is also greatly influenced by microencapsulation technologies due to the benefits achieved by the manufacturers. Along with the encapsulation of drugs, other active ingredients such as peptides, proteins, and DNA/RNA molecules are also encapsulated in the pharmaceutical sector to meet the market demand for value-added products.

[cmipooja]

Global Integrase Inhibitors Market Is Estimated To Witness High Growth Owing To Escalating HIV/AIDS Prevalence

The global Integrase Inhibitors Market is estimated to be valued at US$ 29.34 billion in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period of 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Integrase inhibitors are a class of antiretroviral drugs used for the treatment of HIV/AIDS. They work by blocking the action of the integrase enzyme, which is responsible for inserting the viral genetic material into the DNA of the host cell. This prevents the replication of the virus and helps in controlling the progression of HIV infection. The need for effective anti-HIV drugs has become crucial due to the rising prevalence of HIV/AIDS worldwide. According to the World Health Organization (WHO), approximately 38 million people were living with HIV/AIDS in 2019. This high prevalence has led to increased demand for integrase inhibitors, as they offer several advantages over other antiretroviral drugs, such as improved efficacy, better tolerability, lower toxicity, and ease of administration. Market Key Trends: One key trend driving the growth of the global integrase inhibitors market is the development of novel and more potent drugs. Pharmaceutical companies are constantly investing in research and development activities to discover and develop new integrase inhibitors with improved therapeutic outcomes. For instance, Gilead Sciences recently received approval from the U.S. Food and Drug Administration (FDA) for a new integrase inhibitor called Biktarvy. This drug is a combination of three active ingredients and offers high efficacy with a low risk of drug resistance. PEST Analysis: Political: The political environment plays a crucial role in shaping the regulations and policies related to HIV/AIDS prevention and treatment. Governments across the globe are increasingly focusing on combating the HIV/AIDS epidemic by implementing awareness campaigns, providing access to affordable healthcare services, and ensuring the availability of antiretroviral drugs, including integrase inhibitors. Economic: The economic factors influencing the integrase inhibitors market include healthcare expenditure, affordability, and reimbursement policies. The high cost of integrase inhibitors can pose a challenge in low-income countries, where access to these drugs is limited due to financial constraints. However, government initiatives and collaborations with pharmaceutical companies are aimed at reducing the cost of these drugs and making them more accessible to all. Social: Social factors such as awareness, stigma, and healthcare infrastructure influence the adoption of integrase inhibitors. Increasing awareness about HIV/AIDS and the importance of early diagnosis and treatment is driving the demand for integrase inhibitors. Efforts are being made to reduce the stigma associated with HIV/AIDS, which can affect patients' willingness to seek treatment and adhere to medication regimens. Technological: Technological advancements in drug delivery systems and diagnostics have improved the efficacy and accessibility of integrase inhibitors. The development of long-acting formulations and point-of-care testing methods has facilitated better disease management and monitoring. Furthermore, advancements in genetic engineering techniques have enabled the discovery and development of more potent integrase inhibitors. Key Takeaways: - The Global Integrase Inhibitors Market Size is expected to witness high growth, exhibiting a CAGR of 3.9% over the forecast period. This growth can be attributed to increasing HIV/AIDS prevalence globally and the demand for effective antiretroviral drugs. - Regionally, North America is expected to dominate the market due to a well-established healthcare infrastructure, high healthcare expenditure, and favorable reimbursement policies.

[rahulp3]

Nasal Sprays Market Size and Growth, Industry Analysis, Trends, CAGR, Segmentation, Opportunities, and Forecast 2023 to 2033

By end of 2022, the global Nasal Sprays Market size was held at around US$ 16.9 billion, and it will grow at a CAGR of 6.2% to be worth US$ 32.6 billion by 2033. According to a recent Future Market Insights study, polymers packaging materials are expected to account for 88.3% of the global market in 2023.In 2022, the market value was approximately 23.5% of the overall US$ 71.9 Billion global nasal drug delivery technology market. From 2015 to 2022, the market expanded at a CAGR of 5.8%.

Expand Your Horizons with PDF Sample Downloads. @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13112

Also, growing equipment approvals by regulatory bodies are expected to benefit the market in the forecast period. For instance, in March 2019, FDA approved Spravato nasal spray for curing adult patients with treatment-resistant depression. In 2018, FDA revealed that about 7.4 million adults suffer from treatment-resistant depression in the U.S which widens the scope of suicidal tendencies and hospitalizations. The nasal spray offers drugs in an easy way since it comprises active ingredients and medications which are dissolved in solutions.Players in the market are taking various initiatives to develop the market in the forecast period. Increasing investment in R&D to offer innovative products in the market is likely to prepare a conducive environment for market growth during the forecast period. For instance, in February 2022, Glenmark Pharmaceuticals Ltd., a renowned pharmaceutical company, and Canadian pharmaceutical company SaNOtize Research & Development Corp announced the launch of its Nitric Oxide Nasal Spray under the brand name FabiSpray ® in India. The product aims to kill the COVID-19 virus in the upper airways. Such initiatives are expected to augment the market size in the assessment period.However, nasal may spray result in itchiness, redness, and swelling in the nose, leading to reduced consumption, thus, hindering the market expansion. Further, the regulatory obstructions owing to strict laws for the sales of drugs in countries such as Russia and Mexico are likely to be another potential factor controlling the market growth. For instance, the regulatory authority of Mexico, COFEPRIS, set forth new guidelines for permitting registrations of generic drugs, which is not inclusive of patents of new therapeutic uses in its linkage system

Gather More Insights by Clicking the Link Below @ https://www.futuremarketinsights.com/reports/nasal-spray-market

Key Takeaways from the Market Study:The global nasal spray market is expected to secure a market value worth US$ 3.2 Billion in 2022.The nasal spray market in Europe is expected to display a CAGR of 5.8% during the forecast period.In 2021, the retail segment is expected to have captured about 54% of the global nasal spray market.The nasal spray market in North America is expected to display a CAGR of 6% during the forecast period.Manufacturers are focusing on introducing nasal sprays capable of administering drug formulations with high efficacy and potency. Hence, the introduction of robust product lines has become a reality, leading to a host of new product launches and innovations, remarks an analyst at FMI.Competition Analysis:Key players in the global nasal spray market include Astra Zeneca Plc., Cipla Ltd., Johnson & Johnson Services, Inc. (Johnson & Johnson Pacific Pty Limited), Glaxosmithkline Plc., Novartis International AG, Procter & Gamble, Sanofi S.A. (Sanofi-aventis LLC.), Boehringer Ingelheim GmbH, AdvaCare Pharma, Bayer AG (Bayer Consumer Health, Covis Pharma S.a.r.l., Nipro Corporation (NIPRO JMI Pharma Ltd.), Viatris Inc. (Meda Pharmaceuticals Inc.), Perrigo Company plc, AptarGroup, Inc., Berry Global, Inc., URSATEC GmbH, Gerresheimer AG, Bona, Avantor, VWR International, LLC, Spectrum Laboratory Products, Inc.  (Spectrum Pharmacy Products), SKS Bottle & Packaging, Inc., and Coster Tecnologie Speciali S.p.A.Recent Updates from the Industry:In October 2021, Cipla’s consumer health arm announced an anti-viral nasal spray called Naselin, which contains ‘povidone Iodine’ to protect against coronavirus and respiratory tract infections.In August 2021, CDMO Bora Pharmaceuticals Laboratories Inc. announced its partnership with Kyowa Pharmaceuticals Industry Co. Ltd. The initiative aims to manufacture generic products, including nasal sprays, in Japan.More Valuable Insights:Future Market Insights, in its new offering, presents an unbiased analysis of the global nasal spray market, presenting a historical analysis from 2018 to 2022 and forecast statistics for the period of 2023-2033.Key Players:Astra Zeneca Plc.Cipla Ltd.Johnson & Johnson Services, Inc. (Johnson & Johnson Pacific Pty Limited)Glaxosmithkline Plc.Novartis International AGProcter & GambleSanofi S.A. (Sanofi-aventis LLC.)Boehringer Ingelheim GmbHAdvaCare PharmaBayer AG (Bayer Consumer HealthCovis Pharma S.a.r.l.Nipro Corporation (NIPRO JMI Pharma Ltd.)Viatris Inc. (Meda Pharmaceuticals Inc.)Perrigo Company plcKey Segments Profiled in The Nasal Spray Market ReportProduct:Decongestant SpraysNasal Steroid SpraysNasal Antihistamine SpraysNasal Cromolyn Sodium SpraysNasal Anticholinergic SpraysNasal Triamcinolone SpraysFormulation:AqueousHydroalcoholicNonaqueous-Based SolutionSuspensionEmulsionsDry Powder/Micro particlesPackaging:Pressurized CanistersPump BottlesDistribution Channel:Institutional SalesHospitalsCommunity ClinicsSpecialty ClinicsPublic Health AgenciesVeterinary Hospitals & ClinicsRetail SalesRetail PharmaciesDrug StoresMail Order Pharmacy

[foodandbeverages]

health and medical microalgae Market In-depth Insights, Revenue Details, Regional Analysis by 2033

The health and medical microalgae market is anticipated to secure a valuation of US$ 729 million in 2023 and is predicted to reach US$ 1,337 million by 2033. The market is estimated to capture a CAGR of 6% during the forecast period. 

The market is influenced by several driving factors, including:

²  Growing Awareness of Health: Consumers are increasing the adoption of health and medical microalgae by raising awareness towards health and wellness. It contains high nutrients, minerals, protein, antioxidants, and essential fatty acids that promote a healthy lifestyle. 

²  Increasing Demand for Plant-based Ingredients: The rising consumer demand for plant-based and vegan products is increasing the adoption of microalgae. These consumers are shifting their preferences from animal-derived products.

²  Growing Pharmaceuticals and Nutraceutical Sectors: The pharmaceuticals and nutraceutical sectors are rapidly driving the global market by promoting health-beneficial properties. These sectors produce dietary supplements, pharmaceutical formulations, and functional foods to expand the global market. 

²  Research and Development: The rising research and development activities are key to developing innovative, advanced techniques and high-quality products. These products attract consumers are increasing the demand for microalgae. 

²  Sustainable Production: Microalgae are cultivated in freshwater and seawater with sustainability. It contains a rich source of nutrition and minerals that attract consumers and reduce environmental impacts.

²  Functional Ingredients: Microalgae are widely used for functional ingredients. For instance, chlorella and spirulina are used in functional foods, beverages, and dietary supplements. These products are popular among consumers that prefer plant-based alternatives.

These are a few of the factors that are experiencing steady growth in the global market. The rising demand for nutrients, sustainability, functional ingredients, and consumer awareness is estimated to continue to fuel the global market by 2033.

Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-13515

Key Takeaways:

l  The health and medical microalgae market is estimated to secure a valuation of US$ 1,337 million with a CAGR of 6% by 2033.

l  In the historical period, the market secured a valuation of US$ 647.50 million with a CAGR of 3% in 2022.

l  The United States is estimated to register a share of 24.3% in the global market by 2033.

l  With a share of 9.9%, Germany is significantly growing the global market during the forecast period. 

l  Japan is anticipated to capture a share of 2.0% in the global market by 2033.

How Key Players Upsurge the Global Market?

The number of key players in the region highly fragments the market. These players are innovating new and improved products to upsurge the global market. They are focused on consumers' expectations and develop better products per their requirements. These players adopt several marketing tactics to uplift the global market, mergers, acquisitions, partnerships, product launches, and collaborations. 

The key players are distributing their products in retail shops, online platforms, and social media channels to reach more customers. They also promote their products and educate their consumers by visiting trade shows and exhibitions.

Recent Developments in the Global Market are:

l  In 2021, Sophie's Bionutrients launched its new product provides alternative meat. It is plant-based that made from microalgae. 

l  In 2019, Atacama Bio Natural Products announced its newly launched product NatAxtinTM. It is made from microalgae that contain antioxidant properties and rich nutrients.

Information Source: https://www.futuremarketinsights.com/reports/microalgae-health-and-medical-sector